Revista da Sociedade Brasileira de Medicina Tropical 46(6):691-697, Nov-Dec, 2013http://dx.doi.org/10.1590/0037-8682-0087-2013
INTRODUCTION
ABSTRACT Introduction:Although the initiation of highly active antiretroviral therapy (HAART) is accompanied by an attenuation of viral load, metabolic disorders characterized by hyperglycemia, dyslipidemia, and lipodystrophy are often observed in patients under this treatment. Certain foods, such as oat bran, soy protein, and fl axseed, have been shown to improve a patient's lipid profi le despite possible increases in uricemia. Thus, a bioactive compound was formulated using these foods to help patients with HIV/ AIDS control metabolic disorders resulting from HAART. Methods: An uncontrolled before and after study was performed. The total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, and uric acid before and after 3 months of consuming the formulation were compared in patients. The compound was formulated such that 40g (the recommended daily intake) contained approximately 10g of fl axseed, 20g of oat bran, and 10g of textured soy protein. Results: The study population consisted of 139 patients, 31 of whom were included in the fi nal analysis. There were no signifi cant variations between the laboratory results obtained before and after consumption of the compound. Conclusions: The regular consumption of the formulation together with individualized dietary guidance did not reduce lipid levels and did not contribute to an increase in uricemia in the study group. However, new studies with higher doses of the foods that compose the formulation should be encouraged to investigate whether these foods can positively infl uence the lipid profi les of these patients.